Mass General Brigham has introduced an AI tool called FaceAge that estimates biological age and predicts survival odds. A ...

As medicinal science progresses, researchers have developed an AI mechanism that uses a selfie to determine a patient's ...

Tacrolimus outshined another immunosuppressive drug at extending relapse-free survival in kids with frequently relapsing or ...

The researchers found that cancer patients tend to have a higher biological age as predicted by FaceAge compared to their ...

The new test focuses on mutations in the NPM1 and FLT3 genes, which are among the most common causes of leukemia in younger ...

The comprehensive study, which tracked data spanning 20 years, revealed that not only does pregnancy not negatively impact ...

This study presents a valuable meta-analysis that highlights low and highly variable breast cancer survival rates across Africa, emphasizing the pressing need for public health in Africa. The evidence ...

Researchers sought to determine whether combination therapy with zanubrutinib, obinutuzumab, and venetoclax would be effective for TP53-mutant MCL.

“But the trial included these extra tests in the bone marrow every three months to detect if there’s any evidence of what we ...

Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic ...